INBX Operating Cash Flow (Statement)
Inhibrx Biosciences Inc · Operating Cash Flow (Statement)
INBX Operating Cash Flow (Statement)
Latest reported-$131.89Mperiod ending
INBX Cash from Operations (-$18.11M → -$131.89M)
Annual operating cash flow (statement)
High-resolution chart · PNG
INBX operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -129,794,000 | |
| -194,409,000 | |
| -193,309,000 | |
| -115,301,000 | |
| -80,323,000 | |
| -47,968,000 | |
| -32,079,000 | |
| -23,092,000 | |
| -18,752,000 | |
| -18,108,000 |